{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:22:06Z","timestamp":1789424526427,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-EY008098"],"award-info":[{"award-number":["P30-EY008098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001607","name":"Eye and Ear Foundation of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cbi.2024.110856","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T03:12:01Z","timestamp":1704424321000},"page":"110856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Aldose reductase is a potential therapeutic target for neurodegeneration"],"prefix":"10.1016","volume":"389","author":[{"given":"Mishal","family":"Rao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-5612","authenticated-orcid":false,"given":"Kun-Che","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.110856_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.biocel.2009.09.009","article-title":"Aldose reductase: a novel therapeutic target for inflammatory pathologies","volume":"42","author":"Ramana","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2024.110856_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11100655","article-title":"Physiological and pathological roles of aldose reductase","volume":"11","author":"Singh","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.cbi.2024.110856_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cbi.2011.02.023","article-title":"Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders","volume":"191","author":"Srivastava","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110856_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bcp.2018.01.034","article-title":"Regulation on SIRT1-PGC-1alpha\/Nrf2 pathway together with selective inhibition of aldose reductase makes compound hr5F a potential agent for the treatment of diabetic complications","volume":"150","author":"Wang","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110856_bib5","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1167\/iovs.06-0469","article-title":"Inhibition of aldose reductase prevents lipopolysaccharide-induced inflammatory response in human lens epithelial cells","volume":"47","author":"Pladzyk","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib6","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1210\/en.2017-00294","article-title":"Aldose reductase mediates NLRP3 inflammasome-initiated innate immune response in hyperglycemia-induced Thp1 monocytes and male mice","volume":"158","author":"Pal","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2024.110856_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/bmc.2011.002","article-title":"Aldose reductase: new insights for an old enzyme","volume":"2","author":"Ramana","year":"2011","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.cbi.2024.110856_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.cbi.2024.110856_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/diab.33.6.562","article-title":"Localization of aldose reductase in the human eye","volume":"33","author":"Akagi","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2024.110856_bib10","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1167\/iovs.07-0485","article-title":"Aldose reductase inhibition prevents endotoxin-induced uveitis in rats","volume":"48","author":"Yadav","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/857958","article-title":"Inhibition of ocular aldose reductase by a new benzofuroxane derivative ameliorates rat endotoxic uveitis","volume":"2014","author":"Di Filippo","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.cbi.2024.110856_bib12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.exer.2010.01.012","article-title":"Inhibition of aldose reductase attenuates endotoxin signals in human non-pigmented ciliary epithelial cells","volume":"90","author":"Yadav","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.cbi.2024.110856_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cbi.2012.12.001","article-title":"Beta-glucogallin reduces the expression of lipopolysaccharide-induced inflammatory markers by inhibition of aldose reductase in murine macrophages and ocular tissues","volume":"202","author":"Chang","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110856_bib14","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1167\/iovs.13-13487","article-title":"Aldose reductase inhibition prevents endotoxin-induced inflammatory responses in retinal microglia","volume":"55","author":"Chang","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2016.03.122","article-title":"Aldose reductase mediates retinal microglia activation","volume":"473","author":"Chang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2024.110856_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cbi.2019.01.020","article-title":"Role of aldose reductase in diabetes-induced retinal microglia activation","volume":"302","author":"Chang","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110856_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11070450","article-title":"Diabetes-independent retinal phenotypes in an aldose reductase transgenic mouse model","volume":"11","author":"Petrash","year":"2021","journal-title":"Metabolites"},{"issue":"2023","key":"10.1016\/j.cbi.2024.110856_bib18","first-page":"1598","article-title":"Alzheimer's disease facts and figures","volume":"19","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.cbi.2024.110856_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2024.110856_bib20","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.cbi.2024.110856_bib21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2024.110856_bib22","article-title":"The molecular mechanisms of neuroinflammation in Alzheimer's disease, the consequence of neural cell death","volume":"24","author":"Choi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315088","article-title":"The role of aldose reductase in beta-amyloid-induced microglia activation","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.intimp.2017.06.005","article-title":"Aldose reductase inhibitors attenuate beta-amyloid-induced TNF-alpha production in microlgia via ROS-PKC-mediated NF-kappaB and MAPK pathways","volume":"50","author":"Song","year":"2017","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2024.110856_bib25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2024.110856_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094616","article-title":"Advances in regeneration of retinal ganglion cells and optic nerves","volume":"22","author":"Yuan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-vision-022720-094953","article-title":"Axon regeneration in the mammalian optic nerve","volume":"6","author":"Williams","year":"2020","journal-title":"Annu Rev Vis Sci"},{"key":"10.1016\/j.cbi.2024.110856_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.22516","article-title":"Early microglia activation in a mouse model of chronic glaucoma","volume":"519","author":"Bosco","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.cbi.2024.110856_bib29","first-page":"143","article-title":"The role of microglia in the progression of glaucomatous neurodegeneration- a review","volume":"11","author":"Zeng","year":"2018","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.cbi.2024.110856_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.exer.2011.01.012","article-title":"Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma","volume":"92","author":"Taylor","year":"2011","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.cbi.2024.110856_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.610788","article-title":"The interaction between microglia and macroglia in glaucoma","volume":"15","author":"Zhao","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.cbi.2024.110856_bib32","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/s41598-023-32702-5","article-title":"Aldose reductase inhibition decelerates optic nerve degeneration by alleviating retinal microglia activation","volume":"13","author":"Rao","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.110856_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031031","article-title":"Aldose reductase and the polyol pathway in Schwann cells: old and new problems","volume":"22","author":"Niimi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.110856_bib34","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jdi.13105","article-title":"Painful and non-painful diabetic polyneuropathy: clinical characteristics and diagnostic issues","volume":"10","author":"Gylfadottir","year":"2019","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.cbi.2024.110856_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/NEN.0b013e3181d26487","article-title":"Aldose reductase deficiency improves Wallerian degeneration and nerve regeneration in diabetic thy1-YFP mice","volume":"69","author":"Chen","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.cbi.2024.110856_bib36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.brainres.2008.10.018","article-title":"Thirteen-month inhibition of aldose reductase by zenarestat prevents morphological abnormalities in the dorsal root ganglia of streptozotocin-induced diabetic rats","volume":"1247","author":"Shimoshige","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2024.110856_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdiacomp.2008.10.005","article-title":"Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(varepsilon)-carboxymethyl lysine","volume":"24","author":"Kawai","year":"2010","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.cbi.2024.110856_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.cbi.2024.110856_bib39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.7326\/0003-4819-114-9-720","article-title":"In-vitro assessment of a hypersensitivity syndrome associated with sorbinil","volume":"114","author":"Spielberg","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2024.110856_bib40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/1056-8727(93)90042-W","article-title":"Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group","volume":"7","author":"Santiago","year":"1993","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.cbi.2024.110856_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040485","article-title":"Search of differential inhibitors of aldose reductase","volume":"12","author":"Balestri","year":"2022","journal-title":"Biomolecules"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:14:34Z","timestamp":1757859274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":41,"alternative-id":["S0009279724000024"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110856","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aldose reductase is a potential therapeutic target for neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110856"}}